Skip to main content
. 2020 Jan 28;11(4):378–385. doi: 10.18632/oncotarget.27434

Table 2. Response and Disease Control Rates.

Variable Response at 6 weeks (n=55) Response at 12 weeks (n=50)
No. % 95% CI No. % 95% CI
Complete response 3 5.5% [1.2-15.1] 1 2% [0.05-10.6]
Partial response 26 47.2% [33.7-61.2] 20 40% [26.4-54.8]
Stable disease 19 34.6% [22.2-48.6] 14 28% [16.2-42.5]
Progressive disease 7 12.7% [5.3-24.5] 15 30% [17.9-44.6]
Objective response rate 29 52.7% [38.8-66.3] 21 42% [28.2-56.8]